All Stories

  1. The M 1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes

    Article • Proceedings of the National Academy of Sciences, June 2022, Proceedings of the National Academy of Sciences

    Graeme Milligan

  2. Receptor selectivity between the G proteins Gα12 and Gα13 is defined by a single leucine-to-isoleucine variation

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Graeme Milligan

  3. Design, Synthesis, and Evaluation of a Diazirine Photoaffinity Probe for Ligand-Based Receptor Capture Targeting G Protein–Coupled Receptors

    Article • Molecular Pharmacology, December 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Graeme Milligan

  4. G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35

    Article • British Journal of Pharmacology, November 2017, Wiley

    Graeme Milligan

  5. Antagonist of the receptor FFA4 (GPR120)

    Article • Molecular Pharmacology, April 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Graeme Milligan

  6. Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance

    Article • The FASEB Journal, February 2017, Federation of American Societies For Experimental Biology (FASEB)

    Kenji Ishihara, Graeme Milligan

  7. The Molecular Basis of Oligomeric Organization of the Human M3 Muscarinic Acetylcholine Receptor

    Article • Molecular Pharmacology, March 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Graeme Milligan

  8. G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets

    Article • British Journal Of Nutrition, January 2014, Cambridge University Press

    Graeme Milligan